We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.77%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$82.4B
AUM Growth
-$19B
(-19%)
Cap. Flow
-$13.6B
Cap. Flow
% of AUM
-16.54%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
5,646
New
684
Increased
1,579
Reduced
2,172
Closed
1,173
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.07B |
| 2 |
Microsoft
MSFT
|
+$727M |
| 3 |
Apple
AAPL
|
+$571M |
| 4 |
Meta Platforms (Facebook)
META
|
+$323M |
| 5 |
Marvell Technology
MRVL
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$778M |
| 3 |
JPMorgan Chase
JPM
|
+$225M |
| 4 |
NextEra Energy
NEE
|
+$218M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.95% |
| 2 | Consumer Discretionary | 6.94% |
| 3 | Financials | 4.97% |
| 4 | Industrials | 4.93% |
| 5 | Healthcare | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Arcutis Biotherapeutics
ARQT
$3.55B
| $975K | ﹤0.01% |
62,327
-59,065
| -49% | -$832K |
|
2677
Esquire Financial Holdings
ESQ
$1.1B
| $973K | ﹤0.01% |
12,910
-1,485
| -10% | -$118K |
|
2678
Gildan
GIL
$9.58B
| $973K | ﹤0.01% |
+22,006
| New | +$1.09M |
|
2679
iShares MSCI EAFE Value ETF
EFV
$28.4B
| $970K | ﹤0.01% |
16,460
+9,566
| +139% | +$541K |
|
2680
CALL
Iris Energy
IREN
$12.1B
| $969K | ﹤0.01% |
159,100
-768,300
| -83% | -$7.48M |
|
2681
PUT
Novavax
NVAX
$1.21B
| $969K | ﹤0.01% |
151,100
-174,900
| -54% | -$1.45M |
|
2682
CALL
TransDigm Group
TDG
$73.2B
| $968K | ﹤0.01% |
700
-500
| -42% | -$667K |
|
2683
PUT
Exelon
EXC
$48.4B
| $968K | ﹤0.01% |
21,000
-10,900
| -34% | -$456K |
|
2684
Direxion Daily Technology Bull 3x ETF
TECL
$4.77B
| $968K | ﹤0.01% |
16,522
+2,784
| +20% | +$227K |
|
2685
Sabre
SABR
$743M
| $967K | ﹤0.01% |
344,244
+307,372
| +834% | +$1.09M |
|
2686
ProShares Ultra Russell2000
UWM
$249M
| $967K | ﹤0.01% |
+28,926
| New | +$1.16M |
|
2687
ARS Pharmaceuticals
SPRY
$563M
| $966K | ﹤0.01% |
76,824
+52,047
| +210% | +$626K |
|
2688
CALL
Lemonade
LMND
$4.77B
| $965K | ﹤0.01% |
30,700
-14,600
| -32% | -$502K |
|
2689
PUT
Domino's
DPZ
$11.6B
| $965K | ﹤0.01% |
2,100
-31,400
| -94% | -$14.2M |
|
|
MRP
2690
Millrose Properties Inc
MRP
$4.75B
| $964K | ﹤0.01% |
+36,379
| New | +$852K |
|
2691
Arvinas
ARVN
$529M
| $964K | ﹤0.01% |
137,263
+120,674
| +727% | +$1.89M |
|
2692
Twist Bioscience
TWST
$5.51B
| $961K | ﹤0.01% |
24,487
-3,279
| -12% | -$148K |
|
2693
Gentex
GNTX
$5.12B
| $960K | ﹤0.01% |
41,187
-481,835
| -92% | -$12.3M |
|
2694
VICI Properties
VICI
$29.8B
| $959K | ﹤0.01% |
29,407
+1,083
| +4% | +$33.4K |
|
|
MPT
2695
CALL
Medical Properties Trust
MPT
$2.89B
| $959K | ﹤0.01% |
159,000
-223,400
| -58% | -$1.13M |
|
2696
UBS Group
UBS
$171B
| $958K | ﹤0.01% |
31,292
+19,200
| +159% | +$640K |
|
2697
Kinross Gold
KGC
$28.1B
| $958K | ﹤0.01% |
76,008
-203,654
| -73% | -$2.29M |
|
2698
Kite Realty
KRG
$5.91B
| $956K | ﹤0.01% |
42,747
+9,482
| +29% | +$217K |
|
2699
Weis Markets
WMK
$1.9B
| $956K | ﹤0.01% |
12,403
+8,136
| +191% | +$585K |
|
|
ARR
2700
Armour Residential REIT
ARR
$2.04B
| $955K | ﹤0.01% |
55,869
+23,871
| +75% | +$445K |
|
Similar funds
Squarepoint's Q1 2025 Portfolio in Review
As of Q1 2025, Squarepoint held 5,646 positions worth $82.4B, down 19% from $101B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint withdrew a net $13.6B in Q1 2025, closing 1,173 positions and reducing 2,172 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.7% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Squarepoint opened a new position in State Street SPDR S&P Regional Banking ETF worth $78.2M.
- Squarepoint's largest Q1 2025 buy was State Street SPDR S&P Regional Banking ETF: 1,376,134 shares worth $78.2M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $1.07B increase.
- Squarepoint's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Squarepoint fully exited iShares MSCI EAFE ETF in Q1 2025, selling an estimated $210M.
- Squarepoint's ten largest holdings make up 20% of its $82.4B portfolio in Q1 2025.
- Squarepoint opened 684 new positions and closed 1,173 in Q1 2025.
- Squarepoint's portfolio value fell 19% quarter-over-quarter to $82.4B.
Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.